
- Mount Sinai Doctors
- Treats Children & Adults
- Video Visit Available
- Accepting New Patients
Mark G Lebwohl, MD
Dermatology
About Me
Dr. Mark G. Lebwohl graduated summa cum laude from Columbia College in 1974 and graduated from Harvard Medical School in 1978. He completed residencies in internal medicine and dermatology, both at Mount Sinai.
Dr. Lebwohl has been practicing dermatology since 1983. He is the Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai and Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology. Dr. Lebwohl has served as president of the New York Dermatological Society, the Manhattan Dermatologic Society, and the New York State Society of Dermatology, and as chairman of the Dermatology Section of the New York Academy of Medicine. Dr. Lebwohl is a past chairman of the Psoriasis Task Force of the American Academy of Dermatology, and has directed the AAD's annual Psoriasis Symposium, Diagnostic Update Symposium and Therapeutics Symposium. In 2015-16 he served as President of the American Academy of Dermatology.
Dr. Lebwohl is chairman emeritus of the Medical Board of the National Psoriasis Foundation. He is the founding editor of Psoriasis Forum as well as medical editor of the bulletin of the National Psoriasis Foundation, Psoriasis Advance. He has been on the editorial board of the Journal of the American Academy of Dermatology and the Journal of Skin Cancer. He is editor of the Dermatology Section of Scientific American Medicine and co-Editor-in-Chief of Skin, The Journal of Cutaneous Medicine.
Dr. Lebwohl has chaired numerous symposia and has written or edited several books including the first atlas devoted entirely to cutaneous manifestations of systemic disease, and the leading book on dermatologic therapy, Treatment of Skin Disease, now in its sixth edition. His books have been translated into numerous foreign languages, including French, Portuguese, Chinese and Polish. Other books include Difficult Diagnoses in Dermatology and Psoriasis, Mild-to-Moderate Psoriasis and Moderate-to-Severe Psoriasis. He has authored or co-authored over 700 publications including articles, chapters and abstracts. Dr. Lebwohl is actively involved in clinical trials of many new dermatologic treatments.
In The NewsDr. Lebwohl discusses skin cancer in The Daily News.
The state of Florida requires out-of-state professionals who are registered to provide telehealth services to display a hyperlink to the Florida Department of Health telehealth web page. This allows Florida patients who are receiving medical care by telehealth to confirm the provider’s licensure and Florida registration.
Language
English, Hebrew, Spanish
Position
DEAN FOR CLINICAL THERAPEUTICS, PROFESSOR | Dermatology
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
Clinical Focus
- Actinic Keratosis
- Alopecia Areata
- Atopic Dermatitis
- Biopsy
- Bullous Pemphigoid
- Cutaneous Lymphoma
- Eczema
- Itch
- Psoriasis
- Skin Cancer
- Total Body Skin Exam
- Vitiligo
Video
Education
MD, Harvard Medical School
Residency, Internal Medicine
Mount Sinai Hospital
Residency, Dermatology
Mount Sinai Hospital
Certifications
American Board of Dermatology
American Board of Internal Medicine
Awards
2006
America's Top Doctors
Castle Connolly
Best Doctors
New York Magazine
President's Volunteer Service Award
American Academy of Dermatology Gold Medal
Leadership Circle for Volunteerism
Numerous Presidential Citations
American Academy of Dermatology
Best Teacher & Mentor of the Millenium
Dermatology Residents, Mount Sinai
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- EmblemHealth - HIP-Medicare
- HealthFirst Medicare
- Oscar
- United Health Care - Top Tier
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Systemic Janus kinase inhibitors in the management of granuloma annulare. Scott Stratman, Shivkar Amara, Kathryn Jayne Tan, Elisabeth A. George-Washburn, Neda Shokrian, William Lau, Saakshi Khattri, Mark Lebwohl, Emma Guttman Yassky. Archives of Dermatological Research
- Bimekizumab efficacy and safety through 3 years in patients with moderate-to-severe plaque psoriasis: Long-term results from the BE RADIANT phase IIIb trial open-label extension period. Richard B. Warren, Mark Lebwohl, Diamant Thaçi, Melinda Gooderham, Andreas Pinter, Carle Paul, Paolo Gisondi, Balint Szilagyi, Katy White, Delphine Deherder, Fabienne Staelens, Jérémy Lambert, Bruce Strober. British Journal of Dermatology
- Biologics for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Network Meta-analysis. Mark G. Lebwohl, André Carvalho, Akihiko Asahina, Jianzhong Zhang, Mir Sohail Fazeli, Ellen Kasireddy, Paul Serafini, Thomas Ferro, Ranga Gogineni, Diamant Thaçi. Dermatology and Therapy
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
Care Provider’s Concern
Likelihood to Recommend Care Provider
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Lebwohl during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Evommune, Inc.
- Amgen
- Boehringer Ingelheim International GmbH
- Takeda Pharmaceuticals Of North America, Inc.
- Incyte Corporation
- Mindera
- AltruBio, Inc.
- Celltrion
- Deep Apple Therapeutics
- Facilitation of International Dermatology Education
- Almirall US
- Astrazeneca
- Regeneron Pharmaceuticals, Inc.
- Aikium
- EPI Health
- Oruka Therapeutics
- Foundation for Research and Education in Dermatology
- Galderma
- Dermavant Sciences, Inc
- Bristol-Myers Squibb
- AnaptysBio, Inc
- Seanergy
- Strata
- Castle Biosciences Inc.
- Revolo Biotherapeutics
- IQVIA
- Apogee Therapeutics
- Trevi
- forte biosciences
- Genentech, Inc.
- Avotres Inc.
- Eli Lilly And Company
- Mirum Pharmaceuticals, Inc
- Atomwise
- Verrica
- Arcutis, Inc.
- Dermsquared
- Goodrx-Mayne
- Sun Pharma Global FZE
- LEO Pharma A/S
- Meiji Seika Pharma
- CorEvitas, LLC
- Pfizer Inc., U.S. Pharmaceuticals Group
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.